Parabilis Medicines, Inc. (PBLS)

Market Closed

15 Oct, 08:00 PM

NASDAQ (NGS)

$

25. 18

-0.71

-2.7424%

3.2B Market Cap

- P/E Ratio

- Div Yield

954,610 Volume

- Eps

$ 25.89

Previous Close

Investors:

Add Transaction

Day Range

24.8 26.43

Year Range

20 42.49

Want to track PBLS and more in your Portfolio? 🎯

Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Get Started For Free

Parabilis Medicines, Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
Farallon Capital Farallon Capital Management LLC	2.37M	$64.82M	$59.74M	-$5.08M	-7.84%
John H. Burbank III Passport Capital LLC	500,000	$13.69M	$12.61M	-$1.07M	-7.84%
Brian Baylis Bell Investment Advisors Inc.	451	$12,343.87	$11,356.18	-$987.69	-8%
SRB Steve R. Bailey Frazier Life Sciences Management LP	1.92M	$52.57M	$49.85M	-$2.72M	-5.18%
Regan O'Neill Burkehill Global Management LP	10,000	$273,700	$268,500	-$5,200	-1.9%
Li Peng China Universal Asset Management Co. Ltd.	1,600	$43,792	$41,424	-$2,368	-5.41%
Olga Maltseva Catalio Capital Management LP	824,043	$22.55M	$21.4M	-$1.15M	-5.1%
Christopher C. Powers Farther Finance Advisors, LLC	284	$11,609.92	$7,418.08	-$4,191.84	-36.11%
Raymond Debbane Siren, L.L.C.	2.99M	$81.9M	$75.35M	-$6.55M	-8%
James B. Tananbaum Foresite Capital Management VI LLC	999,044	$27.34M	$25.23M	-$2.12M	-7.75%
Scott Schroeder Longaeva Partners LP	500	$13,685	$12,945	-$740	-5.41%
EG Ethan Gilbert Rialto Wealth Management LLC	508	$13,904	$12,791.44	-$1,112.56	-8%
Yuen Man Lee Persistent Asset Partners Ltd.	4,130	$113,038	$107,958.2	-$5,079.8	-4.49%

1

Blog Affiliate Program Dividend Tracker About Terms Privacy Help Contact Us

2026 © Marketlog. All Rights Reserved.